One needs to closely watch for pricing growth, which was a shade lower than expectations. It possibly reflects upon recent moderation in cost inflation.
China's effort on clean environment has impacted the supply side of Vitamin D3 market – particularly the animal feed market. Price rise has been in this category has been in the order of 3-4x in last one year. Additionally, vitamin D3 prices in the human segment have also risen by 20-25% on account of structural changes like limited supply and increasing awareness.
The stock is currently trading at around 9.8x FY21e earnings and 5.4x EV/EBITDA for FY21e which seems attractive given the growth outlook
Isn’t the newspaper industry, one of oldest pillars of the media and entertainment sector, on the brink of extinction with the advent of the digital world? We don’t think so
While its foray into new products and its available capacity bandwidth have made Atul to meet the improving demand, efforts on backward integration and lower finance cost are expected to aid its bottom-line growth
Strong jewellery offtake in H2 FY19, consequent normalisation of promotional expenses and operational efficiencies in the watches segment are expected to be the major re-rating triggers.
We see a profitable journey for this bank and hence recommend buying into the stock as it has potential to rerate from the current valuation.
At current valuations of 22 times FY19 estimated earnings, the stock is reasonably valued.
Domestic tea portfolio grew by 9 percent in volume terms but on account of competitive intensity value grew by 7 percent only. However, sequentially, there was a marginal market share gain in value terms. Noteworthy category was Green tea, wherein 14 percent volume growth helped in market share gain.
Profitability impact due to reduction in TER on existing assets will be limited or negligible, as HDFC AMC has decided to pass on most of the cost to the distributors. On the incremental flows, the P&L impact will be more gradual.
The bank's Q2 earnings reinforces our belief that it is on track to deliver targeted returns by June 2020
NIIT Technologies exhibited robust all round performance, for Cyient it was a quarter of revival from the lows it had hit in Q1 FY19.For Mindtree, Q2 was not only soft but the management commentary was surprisingly cautious.
Net interest income, the difference between interest earned and interest expended, shot up 55.6 percent year-on-year to Rs 1,078 crore in Q2.
Even though jewellery remains of core importance to Titan’s success, the company has been gradually transitioning itself into a consumer-focused company by foraying into new product categories
In this edition of chemical stock picks from Q1FY19, we highlight a couple of stocks from the fluorochemicals space.
With the carnage in the markets, especially in the mid- and smallcap space, investors should keep these better quality smaller companies on their radar for a phased accumulation for the long term.